Selecta Biosciences Inc

SELB
0,8812
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 02:00:00
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
26/4/202415:09EDGAR2Form DEF 14A - Other definitive proxy statements
26/4/202413:57EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
22/4/202412:25EDGAR2Form 8-K - Current report
19/4/202422:49EDGAR2Form 3 - Initial statement of beneficial ownership of..
11/4/202403:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/4/202403:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/4/202403:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/4/202403:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/4/202403:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/4/202422:29EDGAR2Form SC 13D/A - General statement of acquisition of..
10/4/202422:25EDGAR2Form SC 13D/A - General statement of acquisition of..
10/4/202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/4/202413:00EDGAR2Form 8-K - Current report
01/4/202422:32EDGAR2Form 8-K - Current report
28/3/202422:00EDGAR2Form 8-K - Current report
14/3/202412:55EDGAR2Form 8-K - Current report
07/3/202413:08EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
07/3/202413:06EDGAR2Form 8-K - Current report
05/3/202413:05EDGAR2Form 8-K - Current report
14/2/202423:27EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
14/2/202422:42EDGAR2Form DEF 14A - Other definitive proxy statements
14/2/202418:38EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
31/1/202422:30EDGAR2Form PRE 14A - Other preliminary proxy statements
23/1/202422:05EDGAR2Form 8-K/A - Current report: [Amend]
19/1/202422:12EDGAR2Form 8-K - Current report
12/1/202422:16EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/1/202414:45EDGAR2Form 8-K - Current report
08/1/202413:10GLOBECartesian Therapeutics Highlights Progress and 2024..
08/1/202413:00GLOBECartesian Therapeutics Announces Positive Long-Term..
04/1/202423:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202423:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202423:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202423:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202423:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202423:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202423:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202423:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202423:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/12/202322:28EDGAR2Form 8-A12G - Registration of securities [Section 12(g)]
04/12/202322:39EDGAR2Form D/A - Notice of Exempt Offering of Securities: [Amend]
01/12/202314:31EDGAR2Form S-3/A - Registration statement under Securities Act of..
27/11/202322:18EDGAR2Form 8-K - Current report
22/11/202322:39EDGAR2Form SC 13D - General statement of acquisition of beneficial..
22/11/202322:38EDGAR2Form SC 13D - General statement of acquisition of beneficial..
15/11/202323:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202323:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202323:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202323:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202322:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202322:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: Min: Max:
Chiusura: 0,8812

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network